Page last updated: 2024-08-17

methylene blue and epoxomicin

methylene blue has been researched along with epoxomicin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfano, G; Brindisi, M; Brogi, S; Butini, S; Caldelari, R; Campiani, G; Chemi, G; D'Alessandro, S; Dechering, KJ; Fusi, F; Gemma, S; Gorelli, B; Jez, JM; Koolen, KJM; Lamponi, S; Lee, SG; Parapini, S; Saponara, S; Taramelli, D; Vallone, A1
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA1

Other Studies

2 other study(ies) available for methylene blue and epoxomicin

ArticleYear
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analog
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Antimalarials; Dose-Response Relationship, Drug; Enzyme Inhibitors; Furans; Life Cycle Stages; Malaria, Falciparum; Methyltransferases; Molecular Structure; Parasitic Sensitivity Tests; Piperidines; Plasmodium falciparum; Structure-Activity Relationship

2018
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins

2018